These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 35537503)
1. COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy". Huijboom M; Maarse M; Aarnink E; van Dijk V; Swaans M; van der Heijden J; IJsselmuiden S; Folkeringa R; Blaauw Y; Elvan A; Stevenhagen J; Vlachojannis G; van der Voort P; Westra S; Chaldoupi M; Khan M; de Groot J; van der Kley F; van Mieghem N; van Dijk E; Dijkgraaf M; Tijssen J; Boersma L Am Heart J; 2022 Aug; 250():45-56. PubMed ID: 35537503 [TBL] [Abstract][Full Text] [Related]
2. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial. Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184 [TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs. apixaban (ADALA study). Flores-Umanzor EJ; Cepas-Guillen PL; Arzamendi D; Cruz-González I; Regueiro A; Freixa X J Interv Card Electrophysiol; 2020 Nov; 59(2):471-477. PubMed ID: 32986176 [TBL] [Abstract][Full Text] [Related]
4. Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial. Freixa X; Cruz-González I; Cepas-Guillén P; Millán X; Antúnez-Muiños P; Flores-Umanzor E; Asmarats L; Regueiro A; López-Tejero S; Li CP; Sanchis L; Rodés-Cabau J; Arzamendi D JAMA Cardiol; 2024 Oct; 9(10):922-926. PubMed ID: 39110427 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation. Labori F; Persson J; Bonander C; Jood K; Svensson M Eur Heart J; 2022 Mar; 43(13):1348-1356. PubMed ID: 34919652 [TBL] [Abstract][Full Text] [Related]
6. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience. Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514 [TBL] [Abstract][Full Text] [Related]
7. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282 [TBL] [Abstract][Full Text] [Related]
8. Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment-a systematic review and meta-analysis. Labori F; Bonander C; Persson J; Svensson M J Interv Card Electrophysiol; 2021 Aug; 61(2):215-225. PubMed ID: 33580847 [TBL] [Abstract][Full Text] [Related]
9. LAA occlusion is effective and safe in very high-risk atrial fibrillation patients with prior stroke: results from the multicentre German LAARGE registry. Ansari U; Brachmann J; Lewalter T; Zeymer U; Sievert H; Ledwoch J; Geist V; Hochadel M; Schneider S; Senges J; Akin I; Fastner C Clin Res Cardiol; 2024 Oct; 113(10):1451-1462. PubMed ID: 38294498 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management. Jackson LR; Jackson KP; Thomas KL Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665 [TBL] [Abstract][Full Text] [Related]
12. Lower rate of major bleeding in very high risk patients undergoing left atrial appendage occlusion: A propensity score-matched comparison with direct oral anticoagulant. Magnocavallo M; Della Rocca DG; Vetta G; Mohanty S; Gianni C; Polselli M; Rossi P; Parlavecchio A; Fazia MV; Guarracini F; De Vuono F; Bisignani A; Pannone L; Raposeiras-Roubín S; Lochy S; Cauti FM; Burkhardt JD; Boveda S; Sarkozy A; Sorgente A; Bianchi S; Chierchia GB; de Asmundis C; Al-Ahmad A; Di Biase L; Horton RP; Natale A Heart Rhythm; 2024 Aug; 21(8):1267-1276. PubMed ID: 38246567 [TBL] [Abstract][Full Text] [Related]
13. Short-Term Antiplatelet Versus Anticoagulant Therapy After Left Atrial Appendage Occlusion: A Systematic Review and Meta-Analysis. Osman M; Busu T; Osman K; Khan SU; Daniels M; Holmes DR; Alkhouli M JACC Clin Electrophysiol; 2020 May; 6(5):494-506. PubMed ID: 32439033 [TBL] [Abstract][Full Text] [Related]
14. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation. Mohanty S; Mohanty P; Trivedi C; Assadourian J; Mayedo AQ; MacDonald B; Della Rocca DG; Gianni C; Horton R; Al-Ahmad A; Bassiouny M; Burkhardt JD; Di Biase L; Gurol ME; Natale A J Am Heart Assoc; 2021 May; 10(9):e019664. PubMed ID: 33870705 [TBL] [Abstract][Full Text] [Related]
15. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence. Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992 [TBL] [Abstract][Full Text] [Related]
16. Left Atrial Appendage Occlusion in the Management of Stroke in Patients With Atrial Fibrillation. Ojo A; Yandrapalli S; Veseli G; Karim M; Aronow WS; Sharma M; Frishman WH; Naidu SS; Jacobson JT; Iwai S Cardiol Rev; 2020; 28(1):42-51. PubMed ID: 30520738 [TBL] [Abstract][Full Text] [Related]
17. Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis. Chew DS; Zhou K; Pokorney SD; Matchar DB; Vemulapalli S; Allen LA; Jackson KP; Samad Z; Patel MR; Freeman JV; Piccini JP Ann Intern Med; 2022 Sep; 175(9):1230-1239. PubMed ID: 35969865 [TBL] [Abstract][Full Text] [Related]
18. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE. Besola L; Gregori D; Fiocco A; Colli A Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study. Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932 [TBL] [Abstract][Full Text] [Related]
20. Looking for optimal antithrombotic strategy after transcatheter left atrial appendage occlusion: a real-world comparison of different antiplatelet regimens. Vignali L; Gurgoglione FL; Barocelli F; Cattabiani MA; Solinas E; Maini A; Tadonio I; Benatti G; Pelà G; Coli S; Ardissino D; Niccoli G Int J Cardiol; 2023 Jan; 371():92-99. PubMed ID: 36181948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]